Odisha aims to be among top five bio-tech hubs, to create Rs 25 cr fund

Draft policy provides land on priority for projects, 33% subsidy on plant & machinery; power cost reimbursed at a rupee per unit

Shire buys Baxalta in $32-bn deal
Jayajit Dash Bhubaneswar
Last Updated : Nov 04 2016 | 6:03 PM IST
Aiming to become one of the top five bio-tech hubs in the country, Odisha released the draft of its biotechnology policy on Friday. The policy stresses on creating an enabling environment for biotech investments through strategic partnership initiatives, industrial infrastructure development,  investment assistance and policy interventions.

The policy talks of promoting innovation in research & development (R&D) by providing financial and infrastructural support and also encouraging public-private partnership (PPP) in R&D for sustained growth and international competitiveness.

Biotechnology has been listed as one of the priority sectors under the Industrial Policy Resolution (IPR), 2015 by the Odisha government. The state government has proposed to set up a biotechnology fund with an initial contribution of Rs 25 crore. The fund is expected to be utilised for investments, fund of funds and promotional activities in biotechnology sector in the state.

Among the incentives for investors, the state government has agreed to provide land on priority basis for biotechnology projects, permitting a floor area ratio of 2.0 for units located in the industrial areas and biotechnology parks/SEZs. Power cost for such units would be reimbursed at the rate of one rupee per unit for five years from the date of operations. The state government would also provide 33 per cent subsidy on plant & machinery subject to a ceiling of Rs five crore.

To offer marketing assistance, the state government would establish a dedicated cell within the Directorate of Export Promotion & Marketing to provide export marketing services to biotechnology products and services.

A policy advisory vision group is also proposed to be constituted by the state government. The group would act as a think tank and key advisor on diverse policy related issues. It would also recommend policy advisory to the government on various programmes and initiatives that are relevant to expand and strengthen the biotechnology sector.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 04 2016 | 5:53 PM IST

Next Story